NHIVUNewHold Investment Corp IV

🇺🇸 US
10.32
USD
Analysis Scores
Lothien Robustness Score?
31/100
Weak
Neden bu skor?
Damodaran ?
5/100
ROIC hesaplanamadı: girdi kalemleri okunamadı (veri denetimi gerekiyor); DCF hesaplanamadı (faaliyet kârı veya nakit akışı eksik)
Dalio Risk ?
74/100
Piotroski ?
N/A
Yetersiz çeyrek verisi: 3 mevcut, en az 5 gerekli
Graham ?
-
Yetersiz çeyrek verisi: 3 mevcut, en az 4 gerekli
Active Metric?
1/4
Confidence?
48%
Lothien Robustness Summary
58/100
Lothien Sağlamlık: Orta (58/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 4 | Negatif: 4 | Nötr: 0
Net Kâr Pozitif
Son çeyrekte $1M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+65.6 arttı ($854,000 → $1M). Kısa vadede olumlu momentum.
3 Çeyrek Üst Üste Artış
Son 3 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Güçlü Likidite
Cari oran 2.87x — kısa vadeli borçları rahat karşılıyor.
Yüksek F/K Uyarısı
Trailing F/K: 100.0. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Düşük ROE
ROE: %2.3. Sermaye getirisi yetersiz — enflasyonun altında.
Özkaynak Eriyor
Özkaynak çeyreklik %-103.1 düştü. Zarar veya temettü ile sermaye eriyor.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-22.2 düşebilir. Sonraki bilançoya dikkat.

Data date 2026-11-10 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-11-10
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Düşük
145 days
Annual Volatility ?
%3.6
VaR 95% ?
%0.35
daily max loss
VaR 99% ?
%0.51
daily max loss
CVaR 95% ?
%0.46
expected loss (tail)
Max Drawdown ?
%1.0
24.04.2026 → 29.04.2026
Skewness ?
1.88
Parametrik%0.35
Historik%0.20
Cornish-Fisher%0.16
Return Distribution
Valuation
Potential?
-33.1%
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Net kâr çeyreklik %+65.6 artarak 1.4M USD oldu
Cari oran güçlü: 2.87x — yükümlülükler rahat karşılanıyor
Nakit ve benzerleri: 1.3M USD
İşletme nakit akışı negatif: -238,000 USD
ROA düşük: %0.7
Toplam varlıklar: 205.9M USD (%+0.8)
Özkaynak %-103.1 azaldı → -6.0M USD
İşletme kârı negatif: -464,000 USD — faaliyet zararı
Net işletme sermayesi pozitif: 1.0M USD
İşletme sermayesi değişimi: %-16.9
Son 2 çeyrek ardışık kâr
Fiyat TRAMA-99 hafif altında: %+0.0
Direnç seviyesi: TRAMA-99 = 10.32 USD
Sabit varlık ağırlıklı bilanço: Dönen varlıklar %1
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %2.3
ROE %2.3 — low return on equity.
Valuation
P/E Ratio 100.0x Sector: 26.3x
F/K 100.0x — sector median's (26.3x) %280 above. Expensive zone.
Indebtedness
Current Ratio 2.87x
Current ratio 2.87x — current assets are 2x short-term liabilities. Very healthy liquidity.
Growth
No balance sheet data
Score Explanations
Lothien Robustness
31/100
Weak robustness (31/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-33.1%
Minus %33.1 expected value (6.90) vs current price comparison. 1/4 valuation models could be calculated. Model confidence %48.
Components: PE target: 3.19
Damodaran Valuation
5/100
Very Weak
Dalio Risk Analysis
74/100
Low debt risk (74/100).
Leverage: 50/100 | Debt Service: 100/100 | Quality: 42/100
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
100.0x vs 26.3x
Sector median's %280 above — expensive
↔
TRAMA-99 Trend — Near TRAMA
Price (10.32), TRAMA-99 line (10.32) at close levels (%+0.0). Important decision zone — breakout direction will determine the trend.
Price:: 10.32
TRAMA: 10.32
Difference: %+0.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

NHIVU — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.